PACTR202008567047887招募中3 期
Evaluation of neuroprotective effect of dexmedetomidine in patients undergoing brain tumor resection?
Mona Raafat Elghamry0 个研究点目标入组 40 人开始时间: 2020年5月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •patients aged 20-60 years,
- •ASA class I and II,
- •who undergo elective supratentorial tumor resection surgery
排除标准
- •patient's refusal,
- •pre-existing psychiatric disorders or cognitive dysfunction,
- •cerebral infarction,
- •frontal lesions
- •A-V heart block,
- •patients who need intraoperative blood transfusion or those who need postoperative mechanical ventilation
- •surgery in prone position.
研究者
相似试验
已完成
2 期
Cardio protective effect of dexmedetomidine in CABGmyocardial injury.Other functional disturbances following cardiac surgeryIRCT2016071113456N6Vice chancellor for research of Guilan University of Medical Sciences110
进行中（未招募）
不适用
Role of brain protection drug in epilepsy surgeryCTRI/2016/10/007406ALL INDIA INSTITUTE OF MEDICAL SCIENCES20
招募中
3 期
Comparision of Dexmedetomidine and Fentanyl in pain control.IRCT20200613047760N1Ahvaz University of Medical Sciences56
已完成
不适用
The protective effect of dexmedetomidine against acute kidney injury in sepsisAcute kidney injury in sepsis.acute kidney injury, sepsis, dexmedetomidineTCTR20230925003/A331
已完成
3 期
Dexmedetomidine in rhinoplastyIRCT20211225053519N3Tehran University of Medical Sciences42